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The fragmentations of [MRH]R and [MRNa]R adducts of neutral peptides with blocked N- and C-
termini have been investigated using electrospray ion trapmass spectrometry. TheN-termini of these
synthetically designed peptides are blocked with a tertiarybutyloxycarbonyl (Boc) group, and the C-
termini are esterified. These peptides do not possess side chains that are capable of complexation and
hence the backbone amide units are the sole sites of protonation and metallation. The cleavage
patterns of the protonated peptides are strikingly different from those of sodium ion adducts. While
the loss of the N-terminal blocking group occurs quite readily in the case ofMS/MS of [MRNa]R, the
cleavage of the C-terminal methoxy group seems to be a facile process in the case of MS/MS of
[MRH]R. Fragmentation of the protonated adducts yields only bn ions, while yn and an ions are
predominantly formed from the fragmentation of sodium ion adducts. The an ions arising from the
fragmentation of [MRNa]R lack the N-terminal Boc group (and are here termed an* ions). MS/MS of
[MRNa]R species also yields bn ions of substantially lower intensities that lack the N-terminal Boc
group (bn
). A similar distinction between the fragmentation patterns of proton and sodium ion
adducts is observed in the case of peptides possessing an N-terminal acetyl group. An example of the
fragmentation of the HR and NaR adducts of a naturally occurring peptaibol from a Trichoderma
species confirms that fragmentation of these two ionized species yields complementary information,
useful in sequencing natural peptides. Inspection of the isotopic pattern of bn ions derived from
[MRH]R adducts of peptaibols provided insights into the sequences ofmicroheterogeneous samples.
This study reveals that the combined use of protonated and sodium ion adducts should prove useful
in de novo sequencing of peptides, particularly of naturally occurring neutral peptides with modified
N- and C-termini, for example, peptaibols. Copyright # 2006 John Wiley & Sons, Ltd.
Mass spectrometry is rapidly developing as a powerful and
convenient means of de novo sequencing of peptides and
proteins.1 Mass spectral methods complement the traditional
Edman sequencing method.2 For instance, Chait and co-
workers3 have successfully demonstrated the use of matrix-
assisted laser desorption/ionization mass spectrometry
(MALDI-MS) in conjunction with modified Edman degrada-
tion in solution (the ‘ladder’ method). Consequently, mass
spectrometry, in particular tandem mass spectrometry (MS/
MS), finds major applications in ‘bottom-up’ proteomics,
requiring the use of MS/MS for selection and fragmentation of
ions formed from specific species in peptide mixtures,
generated by protease digestion.4 Mass spectrometric sequen-
cing of peptides is most commonly effected by fragmentation
of the [MþH]þ ions.5–8 The fragmentation is the result of the
inelastic collisions of precursor ions with an inert gas like
helium, leading to collision-induced dissociation (CID), some-
times referred to as collisionally activated dissociation
(CAD).6–8 The resulting fragment (product) ions are then
analyzed using a tandem mass analyzer. Fragmentation is
strongly influenced by the chemical nature of the protein or
peptide. The fragmentation efficiency and distribution of
product ions are dictated by the amino acid composition,
sequence, nature of the peptide backbone (amide vs. N-
alkylated), and the size and gas-phase conformation of the
peptide.9–16
Mass spectral fragmentation patterns are usually inter-
preted for protonated peptides. The backbone fragmentation
is facilitated when protonation occurs at a backbone amide
group, resulting in two distinct principal cleavage modes
which give rise to bn and yn ion series.
5–8,17,18 In peptides
containing residues with side chains that are capable of
complexation, protonation at these sites can influence
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cleavage patterns.11,15,16 Consequently, gaps in the series of
product ions are often observed,making de novo sequencing a
difficult task.
A further complicating feature in mass spectrometric
studies of peptides is the frequent observation of intense
peaks corresponding to Naþ and Kþ adducts under
conventional electrospray and MALDI conditions. Some
recent reports have focused on the problem of enhancing the
intensity of [MþH]þ ions of peptides by suppressing alkali
cation adduct formation.19–21 Nevertheless, metal ion/
peptide adducts have found use in peptide sequencing.
Using linear gramicidin D and cyclic gramicidin S, Cody et al.
demonstrated the usefulness of CID of laser-desorbed
[MþK]þ species to obtain structural information by tandem
Fourier transform mass spectrometry.22 Subsequently, the
gas-phase interactions betweenmetal ions and peptides have
been studied in order to probe preferential binding sites of
cations and their effect on fragmentation.23–35 Most such
studies have focused on short peptides possessing free N-
and C-termini. In these cases, the dominant reaction is the
neutral loss of the C-terminal amino acid, leading to the
formation of cationized bn fragments; this reaction has been
studied in particular for sodiated bn ions.
25–27,29,31,34,35 This
behavior is in contrast to that of the protonated adducts
which give rise to both bn and yn ions, suggesting the
possibility that the sodium ion adducts of peptides may
prove to be better candidates for complete C-terminal
sequencing. Glish and co-workers have clearly demonstrated
that multistage mass spectrometric (MSn) dissociation of
alkali-cationized peptides, in a quadrupole ion trap instru-
ment, gives rise to sequential loss of amino acids from the
C-terminus.34,35 Thus, unlike Edman sequencing, MS/MS of
MþNa]þ triggers a sequential cleavage of residues from the
C-terminus. In principle, mass spectrometric sequencing
using C-terminal cation adducts may prove particularly
useful for N-terminally blocked peptides.
In order to probe the differences between the fragmenta-
tion patterns of protonated and sodiated peptides, we chose
to investigate a series of neutral peptides protected at the N-
terminus with a tert-butyloxycarbonyl (Boc) group and an
esterified C-terminus. The peptides examined in this study,
listed in Table 1, are hydrophobic and adopt well-defined
backbone conformations in solution and in the solid state.36–40
In these sequences, protonation or metallation can occur only
at the backbone amide, urethane or ester functions. The
results described in this report establish dramatically
different cleavage patterns, under electrospray MS/MS
conditions, for the protonated and sodiated species. While
well-developed bn ion series are exclusively observed for
[MþH]þ species, yn ions are predominantly formed from
[MþNa]þ species. Extension to acetylated peptides is also
described. The applicability to sequencing of a microheter-
ogeneous sample of a peptaibol antibiotic is illustrated.
EXPERIMENTAL
Materials
The Boc-protected peptide methyl esters were synthesized by
conventional solution-phase procedures, and characterized as
reported earlier.38,39 These peptides were shown to be
homogeneous; their purity was investigated by high-perfor-
mance liquid chromatography (HPLC) and by 500MHz
1H NMR. The N-acetyl peptide methyl esters were obtained
from the Boc-protected peptides by removing the Boc group
by dissolving the peptide in methanol/trifluoroacetic acid
(6:1, 5 h, room temperature) followed by acetylation using
ammonium bicarbonate and acetic anhydride. The peptaibol
antibiotics (trichotoxins) were isolated from a Trichoderma
culture, and fractionated by reversed-phase HPLC as
described earlier for related fungal peptides.41,42
Mass spectrometry
The electrospray ionization (ESI)-MS/MS data were obtained
using an Esquire 3000-plus mass spectrometer (Bruker
Daltonics) consisting of two octapoles followed by an ion
trap. Helium was used as the collision gas for CID
experiments. The data were analyzed using Esquire data
analysis software, version 3.1. The peptides were dissolved in
methanol and injected directly into the system using a syringe
pump (Cole-Parmer, VernonHills, IL, USA) operated at a flow
rate of about 200–240mLh1.
RESULTS AND DISCUSSION
Model peptides
Figure 1(a) shows the ESI-MS/MS spectrum of the proto-
nated heptapeptide Boc-VALUVAL-OMe (1). Peptide 1 is a
prototypic hydrophobic helical sequence.36,37 Inspection of
the fragmentation pattern reveals a set of bn ions including a
peak at m/z 752.4, corresponding to loss of a methoxy group,
and formally the b7 ion. In contrast, fragmentation of the
MþNa]þ ion at m/z 806.6 yields a completely different set of
Table 1. Peptide sequences and observed m/z values of Hþ/Naþ adductsa,b
Peptides
[MþH]þ [MþNa]þ
ReferencesCalculated Observed Calculated Observed
Boc-VALUVAL-OMe 1 784.8 784.6 806.8 806.6 36,37
Boc-LFVUDALFV-OMe 2 1008.1 1007.6 1030.1 1029.7 38
Boc-VAFUVAFUVAFU-OMe 3 1340.2 1339.7 1362.2 1361.8 39
Boc-VAFUVAFU-OMe 4 937.8 937.7 959.8 959.6 39
Boc-LUVALUVALU-OMe 5 1068.0 1067.8 1090.0 1089.6 40
Ac-LFVUDALFV-OMe 6 950.2 949.7 972.2 971.4
Ac-VAFUVAFU-OMe 7 879.8 879.6 901.8 901.6
a The amino acid single letter codes are: A, alanine F, phenylalanine L, leucine U, a-aminoisobutyric acid V, valine.
b The molecular masses are calculated using average amino acid residue masses.
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fragments (Fig. 1(b)); here the predominant peak corre-
sponds to loss of the N-terminal Boc group, resulting in a
very intense peak at m/z 706.4 corresponding to
[M–BocþHþNa]þ. Interestingly, loss of the Boc group does
not appear to be a favored process in the fragmentation of the
[MþH]þ species. The fragment ions of the [MþNa]þ species
may be assigned as yn ions and an
 ions that are formed after
loss of the Boc group. A limited number of bn
 ions, which
also lack the Boc group, are also observed at substantially
lower abundances. Figure 2 illustrates fragmentation spectra
observed for [MþH]þ and [MþNa]þ ions of the peptide Boc-
LFVUDALFV-OMe (2). Peptide 2 is a prototypic hydrophobic
b-hairpin.38 Inspection of these spectra (Fig. 2) immediately
reveals a striking similarity to those observed in the case of
peptide 1. Once again, [MþH]þ species produce bn ions,
while the [MþNa]þ species undergoes extremely facile loss
of the Boc group and subsequently yields yn and an
 ions.
Boc-VAFUVAFUVAFU-OMe (3) is a long hydrophobic helix
which folds in the solid state into a structure encompassing
almost three complete helical turns.39 The cleavage of its
[MþH]þ species gives an almost complete series of bn ions,
with the predominant species at m/z 1307.7 corresponding to
the loss of a methoxy group from the C-terminus, formally a
b12 ion (Fig. 3(a)). As in the preceding cases, fragmentation of
the [MþNa]þ species of peptide 3 also results in a
distribution of fragments consisting of an
 and yn ions with
facile loss of the Boc group (Fig. 3(b)). Similar results (data
not shown) were obtained for the peptides Boc-VAFUVAFU-
OMe (4)39 and Boc-LUVALUVALU-OMe (5).40 Another
notable feature in the case of MS/MS of [MþNa]þ adducts is
the loss of the tertiary butyl group, identified by a peak
corresponding to [MþNa–56]þ.
Figure 4 summarizes the fragmentationpatterns observed for
the protonated and sodiated species of the five peptides tested
here. Clearly, there is a consistent difference between the two
types of fragmentation patterns. In the case of the [MþH]þ
species the almost exclusive formation of bn ion series is
indicative of protonation of the C-terminus, with successive
loss of residues from this end of the molecule. Indeed, the
absence of yn ions is striking. Figure 5(a) shows a plausible
mechanism for the generation of bn ions, which involves
preferential protonation of the C-terminal ester function. Note
that direct spectroscopic evidence for oxazolone formation
upon CID of peptides has been presented recently.43 The
behavior of the [MþNa]þ species is dramatically different. The
predominant cleavage is loss of the Boc group followed by
formation of yn ion series; the mechanism proposed in Fig. 5(b)
involves the Naþ ion preferentially complexed initially to the
N-terminal Boc group and subsequent fragmentation with
charge retention on the C-terminal fragment with Naþ
complexation to vicinal carbonyl groups.
The Boc-protected peptides were used as test cases because
of their ready availability as synthetic intermediates. In order
to eliminate the possibility of preferential Naþ complexation
by the urethane group, N-acetyl derivatives (that are found
in nature) were also examined. Figure 6 compares the ESI-
MS/MS spectra of Hþ and Naþ adducts of a model
acetylated peptide ester, Ac-LFVUDALFV-OMe (6). The
[MþH]þ species gives rise almost exclusively to the bn ion
series, while, in contrast, the [MþNa]þ ion fragments to yield
Figure 1. ESI-MS/MS spectra of (a) [MþH]þ of peptide 1, Boc-VALUVAL-OMe, and
(b) [MRNa]R of peptide 1, Boc-VALUVAL-OMe.
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Figure 2. ESI-MS/MS spectra of (a) [MþH]þ of peptide 2, Boc-LFVUDALFV-OMe, and
(b) [MRNa]R of peptide 2, Boc-LFVUDALFV-OMe.
Figure 3. ESI-MS/MS spectra of (a) [MþH]þ of peptide 3, Boc-VAFUVAFUVAFU-OMe,
and (b) [MRNa]R of peptide 3, Boc-VAFUVAFUVAFU-OMe.
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yn- and an-type ions of appreciable abundances, although bn
ions of low abundance are also detectable. Similar results
were also observed for another N-acetyl peptide ester, Ac-
VAFUVAFU-OMe (7) (data not shown). While loss of the Boc
group is a facile process on fragmenting Naþ adducts of Boc-
protected peptides (Fig. 5(b)), loss of the acetyl group does
not occur in the case of N-acetyl peptides.
A curious feature of the fragmentation of [MþNa]þ species
of these peptides is the observation of a well-developed
series of an
 ions, which correspond to cleavage of residues
Figure 4. Summary of fragmentation patterns of [MþH]þ and [MþNa]þ ions of neutral peptides under
ESI-MS/MS conditions.
Figure 5. Plausible mechanisms proposed for (a) generation of bn ions from the C-terminal
fragmentation of protonated esters and (b) generation of yn ions from the fragmentation of
[MþNa]þ adducts of N-terminal urethanes.
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from the C-terminal end. Conventionally, an ions are
generated by loss of CO from precursor bn ions.
5 However,
in the present case, the low abundance or absence of the
corresponding bn ions suggests the possibility of direct
generation of the an-type ions. Early studies of fragmenta-
tions of [MþNa]þ ions, most conducted using fast atom
bombardment mass spectrometry (FAB-MS), almost always
examined peptides with unprotected N- and C-termini, and,
in addition, contained complexing side chains.23,24,27–31 In
the case of peptides with a carboxylic acid group at the
C-terminus, binding of Naþ clearly involves this site,
eventually leading to successive loss of residues from the
C-terminus.26,27,29 Many studies of [MþNa]þ ions have used
short free peptides, the enkephalins being notable exam-
ples.25,27,28,30–33,35 One early study using FAB-MS did
address the issue of neutral peptides with modified N-
and C-termini, in which protonation or metallation is
necessarily restricted to the peptide backbone.31
Application to peptaibols
Peptaibols are linear peptide antibiotics, composed of about
15–20 amino acids, produced by soil fungi. They possess an
N-terminal acetyl group, a C-terminal amino alcohol, and are
rich in a-aminoisobutyric acid (Aib: U).44–47 Several of the
longer members have the ability to become accommo-
dated within lipid bilayer membranes, thereby forming ion
channels.44–46 Peptaibol biosynthesis occurs by a non-
ribosomal mechanism, involving peptide synthetases result-
ing in the production of a microheterogeneous family of
peptide metabolites.48–50 Thus far, over 250 sequences have
been reported and are available in a database.51 Based on
sequence, length and functional characteristics, peptaibols
are classified into subfamilies (SFs); the longer peptides
containing 17–20 amino acids are classified in the SF1
subfamily.45,47,51 Trichotoxins are 18-residue peptides
belonging to the SF1 subfamily that are isolated from
Trichoderma viride strain NRRL 5242.52–54 These peptides are
so closely related that molecular masses differing by 1Da,
14Da and isobars (identical molecular masses) are found,
corresponding to exchanges or replacements Gly$Ala
(G$A), Ala$Aib (A$U), Aib$DIva (U$ J) (J: DIva: R-
isovaline), Gln$Glu (Q$E) within their sequences,
resulting in complex microheterogeneous mixtures.
While much of the early sequencing of peptaibols was
performed using FAB-MS, more recently ESI-MS methods
have been applied to study the peptaibols.55–58 Also, the
utility of liquid chromatography coupled to ESI-MS/MS
(both positive and negative ionization modes) has been
demonstrated for the analysis of trichotoxins.54
In the course of a program to screen for new peptaibol
antibiotics from several strains of trichoderma, isolated
from a soil sample, we encountered an apparently
homogeneous HPLC fraction of apparent molecular mass
1717Da ([MþH]þ at m/z 1718.2, [MþNa]þ at m/z 1740.1, see
inset of Fig. 7(a)). Figure 7 compares the ESI-MS/MS
spectra of the [MþH]þ and [MþNa]þ ions, which clearly
reveals the dramatic differences between them. In the case
of [MþH]þ, no peaks are observed between m/z 1150 and
1600, while, in the case of [MþNa]þ ions, the fragments are
more uniformly distributed over the entire mass range. The
sequences of trichotoxins with molecular masses about
1717–1718Da, obtained from the peptaibol database, are
listed in Table 2 along with their calculated monoisotopic
masses. Themicroheterogeneity in the trichotoxin sequences,
Figure 6. ESI-MS/MS spectra of (a) [MþH]þ of peptide 6, Ac-LFVUDALFV-OMe, and
(b) [MRNa]R of peptide 6, Ac-LFVUDALFV-OMe.
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demonstrating the presence of isobars and masses differing by
1Da, is clearly evident. There are two trichotoxin peptaibols
with monoisotopic masses of 1717.1Da, and three molecules of
monoisotopic mass 1718.1Da.
Mass spectrometric fragmentation (CID) of such highly
microheterogeneous peptaibols requires strict unit mass
resolution for precise precursor ion selection and detection of
the product ions. This would enable appropriate assignment
of the product ion spectrum for unambiguous sequencing.
However, in practice, with our ion trap it is not possible to
precisely select masses that differ by 1Da. Hence, more than
one precursor ion will be selected for fragmentation, and the
MS/MS spectra will contain fragment ions obtained from
more than one molecule, thereby rendering the assignment
of the spectra difficult. Here, the MS/MS spectrum of
[MþH]þ precursor ions selected with m/z 1718.2 as the
central value (Fig. 7(a)) shows fragment ions obtained from
more than one type of precursor ion; this is evident from the
presence of pairs of fragment peaks separated by 14 and
15 Th, between m/z 650 and 1150. Figure 8 shows an
expansion of the region between m/z 650 and 1000 from the
MS/MS spectrum of [MþH]þ (Fig. 7(a)), which clearly
depicts fragment peaks separated by 1, 14 and 15Th. This
clearly indicates that the fragment ions are derived from a
mixture of microheterogeneous peptaibol molecules. To
characterize the mixture it is necessary to establish both the
number of peptide components and their precise sequences.
Figure 9 shows the calculatedm/z values of the bn and yn ions
formed from Hþ adducts of six trichotoxin peptaibols,
together with their monoisotopic masses. Peptides I–V are
listed in the database (Table 2), while peptide VI is a new
sequence obtained from sequenceV by exchanging the E and
Q residues in positions 6 and 17. Examination of these six
sequences shows variations in amino acids at positions 2, 6,
11, 16 and 17; G(2)/A(2), E(6)/Q(6), A(11)/U(11), J(16)/U(16)
and Q(17)/E(17).
Figure 7. (a) ESI-MS/MS spectrum of [MþH]þ of peptaibol antibiotic obtained from the fungus
Trichoderma, isolated from a soil sample, precursor ion centred at m/z 1718.2 (inset, note distribution
of isotopic peaks of Hþ and Naþ adducts). (b) ESI-MS/MS spectrum of [MþNa]þ adduct of the peptaibol
mixture, precursor ion centred at m/z 1740.1.
Table 2. Sequences of trichotoxins with their calculated monoisotopic massesa
Peptaibols Sequences Monoisotopic mass (Da) References
Trichotoxin_A-50_H I : Ac–U A U L U Q U U U A A U P L U J Q V–CH2–OH 1717.1 50
Trichotoxin_A-50_I II : Ac–U G U L U Q U U U A U U P L U J Q V–CH2–OH 1717.1 50
Trichotoxin_A-40_V III : Ac–U G U L U Q U U U A U U P L U J E V–CH2–OH 1718.1 51
Trichotoxin_A-40 IV : Ac–U G U L U E U U U A U U P L U J Q V–CH2–OH 1718.1 49
Trichotoxin_A-50_Va V : Ac–U A U L U Q U U U A U U P L U U E V–CH2–OH 1718.1 50
a Sequences are from the peptaibol database.51
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Figure 8. ESI-MS/MS spectrum of [MþH]þ of peptaibol antibiotic, showing expansion of the region
between m/z 650 and 1000 (from Fig. 7(a)). Peak assignments are indicated.
Figure 9. Calculatedm/z values of bn and yn ions of [MþH]þ adducts of six trichotoxin sequenceswith
their monoisotopic masses. The sequences I–V are available in the database (see Table 2) and
sequence VI is new.
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From Figs. 7(a), 8 and 9 it is evident that the fragment ions
formed from the Hþ adduct are all bn-type ions. Using Fig. 9,
the peaks at m/z 468.4, 681.5, 766.5, 851.6, 922.6, 1007.5 and
1092.5 may be interpreted to arise from trichotoxins II and
III, while the fragment ions at m/z 482.6, 695.5, 780.5, 865.6,
936.6, 1007.5 and 1092.5 are assigned to trichotoxin I. The
product ions atm/z 482.6, 695.4, 780.5, 865.6, 936.6, 1021.5 and
1106.5 all arise from trichotoxin V, while the product ions at
m/z 482.6, 696.4, 781.5, 866.6, 937.6, 1022.5 and 1107.6 are
assigned to trichotoxin VI. The intense peaks at m/z 1092.5,
1021.5 and 1022.5 (b12) are due to the cleavage of the Aib–Pro
bond (Figs. 7(a) and 9). Cleavage of the tertiary amide bond
is a facile process, usually observed in the fragmentation
of [MþH]þ. Thus, fragmentation of [MþH]þ corresponds to
preferential cleavage of the Aib–Pro bond, with charge
retention on the N-terminal fragment, subsequently gen-
erating a series of bn ions. Thus, the data from the frag-
mentation of [MþH]þ is consistent with five of the possible
trichotoxin sequences and eliminates the presence of
trichotoxin IV. Indeed, the product ions from the Hþ
adducts are supportive of a new sequence, trichotoxin VI.
In sharp contrast to the Hþ adduct, fragmentation of
[MþNa]þ yields abundant product ions distributed over the
entire mass range between m/z 500 and 1700 (precursor ion
centred atm/z 1740.1, Fig. 7(b)). Using Fig. 9, the product ions
of the Naþ adduct are assigned as sodiated yn, an and bn ions
(note that m/z values of sodiated bn and yn ions are 22Th
higher than those of the ions listed in Fig. 9). Notably, the
majority of the fragment ions correspond to those anticipated
from trichotoxin II. These observations are striking in that
MS/MS of the Naþ adduct of a microheterogeneous peptide
mixture has yielded selective observation of product ions
from just one component. Inspection of Fig. 9 reveals that of
the six sequences being considered, two are neutral (I and II),
while four (III, IV, V, VI) are acidic (contain one E residue
each). Figure 7(b) clearly suggests that ionization of the acidic
trichotoxin components is suppressed, possibly because of
formation of tight ion pairs between the side-chain carboxylic
acid and sodium ions. Using Fig. 9 the distinction between
trichotoxins I and II can be made by inspecting the bn and yn
ion m/z values, as they differ by 14 Th over much of the
sequence. The observed spectrum in Fig. 7(b) clearly
indicates a predominant population of product ions arising
from trichotoxin II only, thereby ruling out the presence of
trichotoxin I in the sample.
Figure 10(a) shows the ESI-MS spectrum recorded after
treating the sample with ammonium acetate, which was
intended to enhance the intensity of the protonated species
relative to that of sodiated species. The two peaks at m/z
1092.4 and 626.2 arise from the cleavage of the Aib–Pro bond
(from Fig. 9, b12
I, b12
II, and b12
III at m/z 1092.5; y6
I and y6
II at
m/z 626.4, with y6
III at m/z 627.4). This further confirms the
labile nature of this tertiary amide bond, which is cleaved
even under the normal electrospray conditions (in-source
fragmentation) without resorting to MS/MS; a similar
observation has been reported previously.55 The MS/MS
Figure 10. (a) ESI-MS spectra of (a) the peptaibol antibiotic treated with ammonium acetate (inset
shows an expansion of the spectrum showing the distribution of isotopic peaks of m/z 626.2).
(b) ESI-MS/MS spectrum ofm/z 1092.4, indicating sequence assignment. (c) ESI-MS/MS spectrum
of m/z 626.2, indicating sequence assignment.
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spectrum of m/z 1092.4 (Fig. 10(b)) is clearly indicative
of the presence of the . . . UUAUU . . . segment and not
. . . UUAAU . . . , thereby confirming the absence of tricho-
toxin I. Furthermore, the isotopic peak distribution of m/z
626.2 (inset of Fig. 10(a)) does not suggest the possibility of
the presence of trichotoxin III in the sample, since y6
II is at
m/z 626.4 and y6
III at m/z 627.4 (Fig. 9). In addition, the MS/
MS spectrum of m/z 626.2 (Fig. 10(c)) is clearly suggestive of
. . . UJQV-CH2–OH.
Thus, the fragmentation studies on [MþH]þ and [MþNa]þ
adducts has aided in the identification of three peptidic
components (trichotoxins II, V and VI) out of six possible
sequences of trichotoxins, from an apparently homogeneous
HPLC fraction. The fragmentation of the Naþ adduct did in
fact help in removing the ambiguities caused by the
microheterogeneity of such peptaibols by suppressing the
ionization of acidic peptides. Thus, Naþ adducts may be of
value in selectively reducing the contribution of acidic
sequences in peptide mixture analysis. Furthermore, the
fragmentations of Hþ and Naþ adducts of both synthetic
neutral peptides (withN- andC-terminimodified) and natural
peptaibols seem to follow almost identical patterns (Fig. 11).
CONCLUSIONS
The results presented here suggest that, for non-polar peptide
sequenceswhere protonation ormetallation is restricted to the
peptide backbone, fragmentations of [MþH]þ and [MþNa]þ
species yield complementary information. The former pro-
vides the bn ion series, while the latter permits observation of
yn ions. This may be useful in the sequencing of many natural
peptides that lack amino acid residues with side chains
capable of providing complexing sites for Hþ and Naþ (for
instance peptaibols). In fact, the utility of both Hþ and Naþ
adducts in the identification of new sequences from a
microheterogeneous mixture from Trichoderma reesei has been
demonstrated by Pocsfalvi and co-workers using liquid
secondary ion mass spectrometry.59
In the present study, the fragmentation of Hþ adducts of a
peptaibol mixture, which gave rise to only bn-type ions,
revealed microheterogeneity of an apparently HPLC-pure
fraction. Fragmentation of [MþH]þ ions has indeed aided in
identifying a new sequence, trichotoxin VI, which is almost
similar to trichotoxin V except that Q and E exchange places
between residues 6 and 17.
The results presented here may be applicable in mass
spectrometric sequencing of peptide metabolites from cells
or cell extracts without extensive fractionation. Also, in the
case of microheterogeneous samples, wherein amino acid
variations occur only at specific positions in the sequence,
complete de novo sequencing may not be necessary. In such
cases, identification of only the variable regions or positions
in the sequence would suffice.
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Figure 11. Summary of cleavage patterns of (a) [MþH]þ ions of synthetic peptides (2 and 6) and of
the natural peptaibol antibiotic (trichotoxin II) and (b) [MRNa]R of synthetic peptides (2 and 6) and of
the natural peptaibol antibiotic (trichotoxin II), under ESI-MS/MS conditions.
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